Earnings release

Moderna, Inc. Moderna, Inc. · Q2 2024

ReportedAug 1, 2024
Period endedJun 30, 2024
Rule of 40n/m

The quarter in short

Revenue $241M, down 29.9% year over year and up 44.3% on the quarter. EPS −$3.33, up 8.0% year over year and down 8.5% on the quarter. Free cash flow −$1.46B, down 26.7% year over year and 22.9% on the quarter.

Reported this quarter

Each tile opens the full quarterly series. Download the numbers as CSV or JSON.

Sources & downloads

Company Published by the company on the day of the release.
HTML Earnings press release Investor relations announcement

Q2 2024 across the sector

Every MRNA quarter